Simplex Trading’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40K | Buy |
+3,543
| New | +$40K | ﹤0.01% | 1477 |
|
2025
Q1 | – | Sell |
-35,125
| Closed | -$297K | – | 3190 |
|
2024
Q4 | $297K | Buy |
35,125
+33,041
| +1,585% | +$279K | ﹤0.01% | 813 |
|
2024
Q3 | $24K | Buy |
2,084
+869
| +72% | +$10K | ﹤0.01% | 1486 |
|
2024
Q2 | $14K | Sell |
1,215
-2,211
| -65% | -$25.5K | ﹤0.01% | 1725 |
|
2024
Q1 | $40K | Buy |
+3,426
| New | +$40K | ﹤0.01% | 1468 |
|
2023
Q4 | – | Sell |
-8,810
| Closed | -$84K | – | 3276 |
|
2023
Q3 | $84K | Buy |
8,810
+7,520
| +583% | +$71.7K | ﹤0.01% | 1049 |
|
2023
Q2 | $11K | Buy |
1,290
+194
| +18% | +$1.65K | ﹤0.01% | 1726 |
|
2023
Q1 | $8K | Buy |
+1,096
| New | +$8K | ﹤0.01% | 1790 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 3366 |
|
2022
Q3 | – | Sell |
-577
| Closed | -$5K | – | 3514 |
|
2022
Q2 | $5K | Buy |
577
+511
| +774% | +$4.43K | ﹤0.01% | 2147 |
|
2022
Q1 | $0 | Buy |
+66
| New | – | ﹤0.01% | 3607 |
|
2021
Q4 | – | Sell |
-3,623
| Closed | -$88K | – | 3641 |
|
2021
Q3 | $88K | Hold |
3,623
| – | – | ﹤0.01% | 1727 |
|
2021
Q2 | $86K | Buy |
3,623
+2,376
| +191% | +$56.4K | ﹤0.01% | 1774 |
|
2021
Q1 | $32K | Sell |
1,247
-6,323
| -84% | -$162K | ﹤0.01% | 1864 |
|
2020
Q4 | $143K | Buy |
+7,570
| New | +$143K | ﹤0.01% | 1156 |
|